D-LAZMI Trademark (Class 5) — Registered Status & Details

The current status of D-LAZMI is "Registered". It was filed on 07/06/2022 at DELHI in Class 5. Status may change over time as the application moves through examination, publication, opposition and registration stages.

D-LAZMI is filed in Class 5, covering: Pharmaceuticals; Antibacterial pharmaceuticals; Homeopathic pharmaceuticals; Capsules, empty, for pharmaceuticals; Pharmaceuticals, medical and veterinary preparations; Capsules sold empty for pharmaceuticals; Pharmaceuticals for treating respiratory diseases; Pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals for the treatment of viral diseases; Pharmaceuticals for the treatment of bone diseases; Skin patches for the transdermal delivery of pharmaceuticals; Injectable pharmaceuticals for treatment of anaphylactic reactions; Capsules made of dendrimer-based polymers, for pharmaceuticals; Pharmaceuticals for the prevention and treatment of cancer; Pharmaceuticals for treating the symptoms of radiation sickness; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Dressings, medical; Medical adhesive tapes; Medical diagnostic reagents; Oxygen for medical purposes; Isotopes for medical use; Glucose for medical purposes; Lecithin for medical purposes; Gases for medical purposes; Siccatives for medical purposes.

D-LAZMI covers: Pharmaceuticals; Antibacterial pharmaceuticals; Homeopathic pharmaceuticals; Capsules, empty, for pharmaceuticals; Pharmaceuticals, medical and veterinary preparations; Capsules sold empty for pharmaceuticals; Pharmaceuticals for treating respiratory diseases; Pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals for the treatment of viral diseases; Pharmaceuticals for the treatment of bone diseases; Skin patches for the transdermal delivery of pharmaceuticals; Injectable pharmaceuticals for treatment of anaphylactic reactions; Capsules made of dendrimer-based polymers, for pharmaceuticals; Pharmaceuticals for the prevention and treatment of cancer; Pharmaceuticals for treating the symptoms of radiation sickness; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Dressings, medical; Medical adhesive tapes; Medical diagnostic reagents; Oxygen for medical purposes; Isotopes for medical use; Glucose for medical purposes; Lecithin for medical purposes; Gases for medical purposes; Siccatives for medical purposes.

The exact word "D-LAZMI" is already on record at the Indian Trademark Registry under Application No. 5478254. If you intend to use a similar mark for similar goods or services, you should conduct a comprehensive availability search and consult a trademark attorney before filing. Registerkaro offers a free availability check followed by professional filing.

D-LAZMI is valid up to 07/06/2032. Indian trademarks are valid for 10 years from the date of registration and can be renewed indefinitely in 10-year blocks.

If D-LAZMI is in the "Advertised before Acceptance" or "Accepted & Advertised" stage, you have a 4-month window from publication in the Trade Marks Journal to file an opposition (Form TM-O) at the same Trade Marks Registry office. Grounds typically include prior rights, descriptiveness or bad faith. Registerkaro can prepare and file a Notice of Opposition for you.